Gene expression profiling of clinical stages II and III breast cancer

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 8, 2006, Pages 1101-1113

  Folgueira, M A A K ^a   Brentani, H ^b   Katayama, M L H ^a   Patrao D F C ^b   Carraro, D M ^b   Netto, M Mourão ^b   Barbosa, E M ^d   Caldeira, J R F ^e   Abreu, A P S ^d   Lyra, E C ^d   Kaiano, J H L ^c   Mota, L D ^b   Maciel, M S ^b   Dellamano, M ^b   Caballero, O L S D ^c   Brentani, M M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^d Instituto Brasileiro de Controle do Cancer   (Brazil)

^e Hospital Amaral Carvalho   (Brazil)

Author keywords

Breast cancer; CDNA microarray; Clinical stage; Gene expression

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; COMPLEMENTARY DNA; HEME OXYGENASE 1; MAX PROTEIN; ONCOPROTEIN; PROTEIN KRT15; PROTEIN KRT19; PROTEIN S100A14; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; TREATMENT OUTCOME;

EID: 33747363388     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000800013     Document Type: Article

References (37)

1. Fisher B, Osborne CK, Margolese AG, Bloomer W. Neoplams of the breast. In: Holland IF, Frei E, Bast RC, Kufo DW, Morton DL, Weichselbaum RR (Editors),Cancer medicine. Philadelphia: Lea & Febiger; 1997. p 2349-2429.
2. Hellman S, Harris JR. Natural history of breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK (Editors), Diseases of the breast Philadelphia: Lippincott Williams & Wilkins; 2000.
3. Martin KJ, Kritzman BM, Price BM, Koh B, Kwan CP, Zhang X, et al. Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res 2000; 60: 2232-2238.
4. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10869-10874.
5. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A 2001; 98: 11462-11467.
6. van't Veer U, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536.
7. van de Vijver MJ, He YD, van't Veer LJ, Dal H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999-2009.
8. Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, et al. Gene expression profiles of human breast cancer progression. Proc Nati Acad Sci U S A 2003; 100: 5974-5979.
9. Sotiriou C, Neo SY, McShane LM, Kom EL, Long PM, Jazaeri A, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003; 100: 10393-10398.
10. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natt Acad Sci U S A 2001; 98: 15149-15154.
11. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, at al. Gone-expression profiles to predict distant metastasis of lymphnode-negative primary breast cancer. Lancet 2005; 365: 671-679.
12. Folgueira MA, Carraro DM, Brentani H, Patrao DF, Barbosa EM, Netto MM, et al Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res 2005; 11: 7434-7443.
13. Dias Neto E, Correa RG, Verjovski-Almeida S, Briones MR, Nagai MA, da Silva IN Jr, et al. Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. Proc Nad Acad Sci U S A 2000; 97: 3491-3496.
14. Brentani H, Caballero OL, Camargo AA, da Silva AM, da Silva W Jr, Dias Neto E, et al. The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Aced Sci U S A 2003; 100: 13418-13423.
15. Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM. High-fidelity mRNA amplification for gene profiling. Nat Biotechnol 2000; 18: 457-459.
16. Jones C, Mackay A, Grigoriadis A, Cossu A, Reis-Filho JS, Fulford L, et al. Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. Cancer Res 2004; 64: 3037-3045.
17. Saeed Al, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003; 34: 374-378.
18. Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res 2002; 62: 4427-4433.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCIR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
20. loachim E, Charchanti A, Briasoulis E, Karavasilis V, Tsanou H, Arvanitis DL, et al. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer 2002; 38: 2362-2370.
21. Palacios J, Benito N, Pizarro A, Suarez A, Espada J, Cano A, et al. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am J Pathol 1995; 146: 605-612.
22. Petersen OW, Lind NH, Gudjonsson T, Villadsen R, Ronnov-Jesse L, Bissell MJ. The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Breast Cancer Res 2001; 3: 213-217.
23. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002; 40: 403-439.
24. Sun HQ, Kwiatkowska K, Wooten DC, Yin HL. Effects of CapG overexpression on agonist-induced motility and second messenger generation. J Cell Biol 1995; 129: 147-156.
25. Berditchevski F. Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci 2001; 114: 4143-4151.
26. Peters DG, Kudla DM, Deloia A Chu TJ, Fairfull L, Edwards RP, et al. Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serlial analysis of gene expression. Cancer Epidemiol Biomarkers Prev 2005; 14: 1717-1723.
27. + exchanger-1 induces cytoskeletall changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells. Breast Cancer Res 2004; 6: R616-R628.
28. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33: 49-54.
29. Gergely F, Draviam VM, Raff JW. The ch-TOG/XMAP215 protein is essential for spindle pole organization in human somatic cells. Genes Dev 2003; 17: 336-341.
30. Schumacher AJ, Nissley DV, Harris RS. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc Natl Acad Sci U S A 2005; 102: 9854-9859.
31. Eissenberg JC, Elgin SC. The HP1 protein family: getting a grip on chromatin. Curr Opin Genet Dev 2000; 10: 204-210.
32. Fang J, Sawa T, Akaike T, Akuta T, Sahoo SK, Khaled G, et al. In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. Cancer Res 2003; 63: 3567-3574.
33. Liu N, Bi F, Pan Y, Sun L, Xue Y, Shi Y, et al. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RHoA expression and activity. Clin Cancer Res 2004; 10: 6239-6247.
34. Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J, et al. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 2003; 6: 15-24.
35. Mayerhofer M, Florian S, Krauth MT, Aichberger KJ, Bilban M, Marculescu R, et al. Identification of heme oxygenase-1 as a novel BCR/ ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res 2004; 64: 3148-3154.
36. Berberat PO, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Kunzli B, et al. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 2005; 11: 3790-3798.
37. Hill M, P M, Pereira V, Chauveau C, Zagani R, Remy S, Tesson L, et al. Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indolearnine 2,3-dioxygenase. FASEB J 2005; 19: 11 957-168.